Tandem Diabetes Care Inc.

Company Snapshot

Founded: 2006
Entity Type: Public
Employees: 2,650
Region: U.S.
Revenue: $940.2 Millions
Revenue Year: 2024
Headquarter: California, U.S.
Key Geographics: U.S., Others
Corporate Address: 12400 High Bluff Drive San Diego California, 92130 U.S. Tel. +1-858-366-6900 www.tandemdiabetes.com

Company Overview

Tandem Diabetes Care markets medical devices for individuals with insulin-dependent diabetes within the U.S. The company offers t:slim X2 insulin delivery system, comprising the t:slim X2 pump, a 300-unit disposable insulin cartridge, and an infusion set. Tandem also develops the t:slim X2 Insulin Delivery System featuring Basal-IQ Technology, the t:slim X2 with G5 Integration, and the Tandem Device Updater, which enables users to update their pump’s software.

The company also offers t:connect diabetes management application, a cloud-based data management application that provides a visualization to display therapy management data from the pump and supported by the blood glucose meters for users, caregivers and healthcare providers. Its products in development include the t:slim X2 with control IQ technology, the t:sport insulin delivery system and various connected (mobile) health offerings.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Tandem Diabetes Care Inc. In Reports

Global MedTech Healthcare IT Industry Competitive Landscape

BCC Research Market Analyst says global market for medical devices was valued at $810.4 billion in 2024 and is projected to reach $1.4 trillion by the end of 2030.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

BCC Research Market Analyst says global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028 at a CAGR of 9.8%.

Global Markets for Diabetes Therapeutics and Diagnostics

BCC Market Research Report for Diabetes Therapeutics & Diagnostics provides a detailed review including diabetes medications, insulin delivery devices, monitoring devices, and insulin pumps.

Company's Business Segments

  • Pump : Tandem Mobi and t:slim X2 Insulin Pump, both of which feature Control-IQ advanced hybrid closed-loop technology.
  • Supplies and Other : CGM-related supplies, such as Sensors, Transmitters.

Applications/End User Industries

  • Healthcare
AI Sentiment